Measurement of tumour size in case selection for breast cancer therapy by clinical assessment and ultrasound

European Journal of Surgical Oncology

Volumn 30, Issue 1, 2004, Pages 5-9

  Snelling, J D ^a   Abdullah, N ^a   Brown, G ^a   King, D M ^a   Moskovic, E ^a   Gui, Gerald P H ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Breast cancer; Breast cancer size; Clinical assessment; Ultrasound assessment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECHOMAMMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MASTECTOMY; NEEDLE BIOPSY; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; TUMOR VOLUME;

EID: 0842302478     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2003.10.003     Document Type: Article

References (22)

1. Bonadonna G, Zambetti M, Moliterni A, et al. Recent information from the Milan Cancer Institute on adjuvant and neoadjuvant therapy in high-risk breast cancer. In: Salmon SE (ed.) Adjuvant therapy of cancer VII. Philadelphia: Lippincott, 1993. p. 141-147.
2. Bonadonna G, Valagussa P, Brambilla C, Ferrari L, Moliterni A, Teneziani M, Zambetti M. Primary chemotherapy in operable breast cancer: eight year experience at the Milan Cancer Institute. J Clin Oncol 1998;15(1):93-100.
3. Miller WR, Dixon JM. Endocrine and clinical endpoints of exemestane as neoadjuvant therapy. Cancer Control 2002; 9(2):9-15.
4. Moertal CG, Hanley JA. The effect of measuring error on the results of therapeutic trials in advanced cancer. Cancer 1976;38:388-394.
5. Gawne-Cain ML, Smith E, Darby M, Given-Wilson R. The use of ultrasound for monitoring breast tumour response to proadjuvant therapy. Clin Radiol 1995;50(10):681-686.
6. Davis PL, Staiger MJ, Harris KB, Ganott MA, Klementaviciene J, McCarty KS Jr., Tobon H. Breast cancer measurements with magnetic resonance imaging, ultrasonography and mammography. Breast Cancer Res Treat 1996;37(1):1-9.
7. Fornage BD, Toubas O, Morel, M. Clinical, mammographic, and sonographic determination of preoperative breast cancer size. Cancer 1987;60(4):765-771.
8. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1(8476):307-310.
9. Whitehouse PA, Baber Y, Brown G, Moskovic E, King DM, Gui GP. The use of ultrasound by breast surgeons in outpatients: an accurate extension of clinical diagnosis. Eur J Surg Oncol 2001;27(7):611-616.
10. Rizzatto GJ. Towards a more sophisticated use of breast ultrasound. Eur Radiol 2001;11(12):2425-2435.
11. Zonderlands HM, Hermans J, Coerkamp EG. Ultrasound variables and their prognostic value in a population of 1103 patients with 272 breast cancers. Eur Radiol 2000;10(10): 1562-1568.
12. Hashimoto H, Suzuki M, Oshida M, Nagashima T, Yagata H, Shishikura T, Imanaka N, Nakajima N. Quantitative ultrasound as a predictor of node metastases and prognosis in patients with breast cancer. Breast Cancer 2000;7(3): 241-246.
13. Tressera F, Feu J, Grases PJ et al. Ultrasonographic detection of normal lymph nodes in patients with breast cancer. Br J Radiol 1999;72:827-829.
14. De Kanter AY, Van Eijck CH, van Geel AN et al. Multicentre study on ultrasonographically guided axillary core biopsy in patients with breast cancer. Br J Surg 1999;86:1459-1462.
15. Finlayson CA, MacDermott TA. Ultrasound can estimate the pathologic size of infiltrating ductal carcinoma. Arch Surg 2000;135(2):158-159.
16. Pain JA, Ebbs SR, Hern RP, Lowe S, Bradbeer JW. Assessment of breast cancer size: a comparison of methods. Eur J Surg Oncol 1992;18(2):44-48.
17. Young AE. The surgical management of early breast cancer. Int J Clin Pract 2001;55(9):603-608.
18. Feldman LD, Hortobagyi GN, Buzdar AU, Ames FC, Blumenschein GR. Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res 1986;46:2578-2581.
19. Herrada J, Iyer RB, Atkinson EN, Sneige N, Buzdar AU, Hortobagyi GN. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. Clin Cancer Res 1977;3: 1565-1569.
20. Forouhi P, Walsh JS, Anderson TJ, Chetty U. Ultrasonography as a method of measuring breast tumour size and monitoring response to primary systemic treatment. Br J Surg 1994;81: 223-225.
21. Seymour MT, Moskovic EC, Walsh G, Trott P, Smith IE. Ultrasound assessment of residual abnormalities following primary chemotherapy for breast cancer. Br J Cancer 1997; 76(3):371-376.
22. Weatherall PT, Evans GF, Metzger GJ, Saborrian MH, Leitch AM. MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with X-ray and palpation. J Magn Reson Imaging 2001;13(6):868-875.